Long Yuan

Dr. Long Yuan

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Cell Metabolism
Verified
Journal Article
Closed access
TKTodd G. Kirchgessner
Todd G. Kirchgessner
PSPaul Sleph
Paul Sleph
JOJacek Ostrowski
Jacek Ostrowski
JLJohn Lupisella
John Lupisella
CRCarol S. Ryan
Carol S. Ryan
RFRobert J.A. Frost
Robert J.A. Frost

1 May 2011 in Cancer Prevention Research
Verified
Journal Article
Closed access
PDF file
RBRichard B. van Breemen
Richard B. van Breemen
RSRoohollah Sharifi
Roohollah Sharifi
MVMarlos Viana
Marlos Viana
NPNatasa Pajkovic
Natasa Pajkovic
DZDongwei Zhu
Dongwei Zhu
MSMaria Stacewicz-Sapuntzakis
Maria Stacewicz-Sapuntzakis
Consumption of tomato products is associated with a decreased risk of developing prostate cancer, and lycopene, the red carotenoid in the tomato, is a potent antioxidant that might contribute to this chemoprevention activity. A double-blind, randomized, placebo-controlled trial of 105 African American men veterans, recommended for prostate biopsy to detect cancer, was carried out to investigate whether oral administration of lycopene increases lycopene levels in blood and prostate tissue and lowers markers of oxidative stress. Urology patients were randomly assigned to receive 30 mg/d of lycopene as a tomato oleoresin or placebo for 21 days prior to prostate biopsy for possible diagnosis of prostate cancer. A total of 47 men had a diagnosis of prostate cancer, and 58 men had a diagnosis of benign prostate hyperplasia. Diet, smoking, and drinking habits were assessed. For the men receiving lycopene, the mean lycopene concentration increased from 0.74 ± 0.39 to 1.43 ± 0.61 μmol/L in plasma (P < 0.0001) and from 0.45 ± 0.53 to 0.59 ± 0.47 pmol/mg in prostate tissue (P = 0.005). No significant changes in the DNA oxidation product 8-oxo-deoxyguanosine and the lipid peroxidation product malondialdehyde were observed in prostate tissue and plasma, respectively, as a result of lycopene administration. Cancer Prev Res; 4(5); 711–8. ©2011 AACR.

4 May 2012 in Rapid Communications in Mass Spectrometry
Verified
Journal Article
Closed access
PDF file
LYLong Yuan
Long Yuan
DZDuxi Zhang
Duxi Zhang
MJMohammed Jemal
Mohammed Jemal
AAAnne‐Francoise Aubry
Anne‐Francoise Aubry

1 April 2015 in Journal of Chromatography B
Verified
Journal Article
Closed access
NZNaiyu Zheng
Naiyu Zheng
LYLong Yuan
Long Yuan
QJQin C. Ji
Qin C. Ji
HMHeidi Mangus
Heidi Mangus
YSYan Song
Yan Song
MAMark E. Arnold
Mark E. Arnold

17 December 2012 in Bioanalysis
Verified
Journal Article
Closed access
LYLong Yuan
Long Yuan
MAMark E Arnold
Mark E Arnold
AAAnne-Françoise Aubry
Anne-Françoise Aubry
QJQin C Ji
Qin C Ji
Fast, efficient and reproducible digestion is critical for LC-MS/MS quantitative bioanalysis of therapeutic proteins. Traditional digestion methods require a pretreatment, such as sequential denaturation, reduction and alkylation, which are very time-consuming. Pellet digestion, which does not require the serial pretreatments of denaturation, reduction and alkylation, was evaluated using a test monoclonal antibody (mAb) with 16 disulfide bonds, and compared with traditional digestion methods. For the test mAb, pellet digestion provided much better digestion efficiency compared with direct digestion, and provided similar or better digestion efficiency compared with digestion-with-pretreatment. In particular, for two peptides with very low digestion efficiency under direct digestion, pellet digestion improved the digestion yield by approximately 30-fold, which was similar to or better than what digestion-with-pretreatment offered. This method was then successfully applied to an LC-MS/MS assay of the test mAb in monkey serum. Pellet digestion will be a very useful technique for high-throughput and reliable LC-MS/MS bioanalysis of mAbs and other large proteins, including ones with multiple disulfide bonds.

8 February 2023 in Molecules
Verified
Journal Article
Open access
PDF file
LYLong Yuan
Long Yuan
JDJean-François Dupuis
Jean-François Dupuis
KMKevork Mekhssian
Kevork Mekhssian
Therapeutic oligonucleotides, such as antisense oligonucleotide (ASO) and small interfering RNA (siRNA), are a new class of therapeutics rapidly growing in drug discovery and development. A sensitive and reliable method to quantify oligonucleotides in biological samples is critical to study their pharmacokinetic and pharmacodynamic properties. Hybridization LC-MS/MS was recently established as a highly sensitive and specific methodology for the quantification of single-stranded oligonucleotides, e.g., ASOs, in various biological matrices. However, there is no report of this methodology for the bioanalysis of double-stranded oligonucleotides (e.g., siRNA). In this work, we investigated hybridization LC-MS/MS methodology for the quantification of double-stranded oligonucleotides in biological samples using an siRNA compound, siRNA-01, as the test compound. The commonly used DNA capture probe and a new peptide nucleic acid (PNA) probe were compared for the hybridization extraction of siRNA-01 under different conditions. The PNA probe achieved better extraction recovery than the DNA probe, especially for high concentration samples, which may be due to its stronger hybridization affinity. The optimized hybridization method using the PNA probe was successfully qualified for the quantitation of siRNA-01 in monkey plasma, cerebrospinal fluid (CSF), and tissue homogenates over the range of 2.00–1000 ng/mL. This work is the first report of the hybridization LC-MS/MS methodology for the quantification of double-stranded oligonucleotides. The developed methodology will be applied to pharmacokinetic and toxicokinetic studies of siRNA-01. This novel methodology can also be used for the quantitative bioanalysis of other double-stranded oligonucleotides.